22-22646437-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_199127.3(GGTLC2):c.92C>T(p.Thr31Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000538 in 1,522,780 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_199127.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000215 AC: 31AN: 144494Hom.: 1 Cov.: 21
GnomAD3 exomes AF: 0.0000837 AC: 17AN: 203174Hom.: 3 AF XY: 0.0000183 AC XY: 2AN XY: 109324
GnomAD4 exome AF: 0.0000370 AC: 51AN: 1378194Hom.: 3 Cov.: 35 AF XY: 0.0000204 AC XY: 14AN XY: 684736
GnomAD4 genome AF: 0.000214 AC: 31AN: 144586Hom.: 1 Cov.: 21 AF XY: 0.000229 AC XY: 16AN XY: 69938
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.92C>T (p.T31M) alteration is located in exon 1 (coding exon 1) of the GGTLC2 gene. This alteration results from a C to T substitution at nucleotide position 92, causing the threonine (T) at amino acid position 31 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at